Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP-EBMT analysis on patients with AML in remission

Ruggeri A.; Labopin M.; Ciceri F.; Mohty M.; Nagler A.

首页> 外文期刊>Bone marrow transplantation >Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP-EBMT analysis on patients with AML in remission

【24h】

Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP-EBMT analysis on patients with AML in remission

机译：基于注册表的研究的无GvHD，无复发生存期的定义：缓解期AML患者的ALWP-EBMT分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Bone marrow transplantation》 |2016年第4期|共2页
作者
Ruggeri A.; Labopin M.; Ciceri F.; Mohty M.; Nagler A.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP-EBMT analysis on patients with AML in remission [J] . Ruggeri A., Labopin M., Ciceri F., Bone marrow transplantation . 2016,第4期

机译：基于注册表的研究的无GvHD，无复发生存期的定义：缓解期AML患者的ALWP-EBMT分析
2. A survival study of uterine cervical patients in the North East India: Hospital-cancer registry-based analysis [J] . Amal Chandra Kataki, Jagannath Dev Sharma, Manigreeva Krishnatreya, Journal of Cancer Research and Therapeutics . 2018,第5期

机译：印度东北子宫子宫颈患者的生存研究：基于医院癌症的注册管理分析
3. The Impact of Hematopoietic Cell Transplantation on Survival: An Exploratory Analysis of a Phase 3 Study of CPX-351 Versus 7+3 in Older Patients with Newly Diagnosed, High-Risk/Secondary AML [J] . Lin Tara L., Cortes Jorge E., Newell Laura F., Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：造血细胞移植对生存的影响：对新诊断，高风险/二次AML的老年患者CPX-351对7 + 3相的探索性分析
4. Machine learning of patient similarity: A case study on predicting survival in cancer patient after locoregional chemotherapy [C] . 2010 IEEE International Conference on Bioinformatics and Biomedicine Workshops . 2010

机译：患者相似性的机器学习：预测局部化疗后癌症患者生存率的案例研究
5. Time spent in complete remission (CR) and overall survival (OS) in AML patients. [D] . Sandhu, Vicky. 2014

机译：AML患者花费在完全缓解（CR）和总体生存（OS）上的时间。
6. Superior GVHD-free relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia [O] . Qian Fan, Hui Liu, Xinquan Liang, 2017

机译：G-BM移植至G-PBSC移植物的无GVHD无复发的优异生存率与急性白血病患者同种异体移植物中较高的MDSCs含量有关
7. Duration of first remission and hematopoietic cell transplantation-specific comorbidity index but not age predict survival of patients with AML transplanted in CR2: a retrospective multicenter study [O] . F V Michelis, E G Atenafu, S Couban, 2016

机译：第一次缓解和造血细胞移植特异性合并症的持续时间，但不是年龄预测在CR2中移植的AML患者的存活：回顾性多中心研究

Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP-EBMT analysis on patients with AML in remission

著录项

相似文献

相关主题

期刊订阅